In this presentation, we will discuss the challenges and opportunities presented by these shifts and the impact on traditional eClinical technology companies as the industry moves more toward decentralized trials.
TORONTO (PRWEB)
July 02, 2020
While the regulatory bodies have supported decentralization of clinical trials, prior to COVID-19 many sponsors were reluctant to adopt these tools in practice. The global pandemic has forced many to re-evaluate their stance on remote eClinical solutions. In this presentation, we will discuss the challenges and opportunities presented by these shifts and the impact on traditional eClinical technology companies as the industry moves more toward decentralized trials.
Join David Botts, Executive Vice President, Rose Research and Fred Martin, Chief Product Officer, Medrio in a live webinar on Tuesday, July 21, 2020 at 10am EDT (3pm BST/UK).
For more information or to register for this event, visit Ready or Not, COVID-19 Necessitates the Move to Decentralized Clinical Trials.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Share article on social media or email: